Over-expression of miR-21 has been demonstrated in the lungs of patients with IPF and in animal models of lung fibrosis, suggesting it may function via reduction of Smad7, a downstream inhibitor of TGF-beta signaling [15]. This evidence concerns the gene SMAD7 and pulmonary fibrosis.